Urination Disorders
Welcome,         Profile    Billing    Logout  
 37 Companies   62 Products   62 Products   62 Mechanisms of Action   5 Trials   685 News 


«12345678910111213...1314»
  • ||||||||||  Soliris (eculizumab) / AstraZeneca
    Trial completion:  Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria (clinicaltrials.gov) -  Jun 30, 2017   
    P3,  N=87, Completed, 
    Recruiting --> Completed | N=40 --> 60 No longer recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change:  SOLECT: Solace European Confirmatory Trial (clinicaltrials.gov) -  Jun 23, 2017   
    P=N/A,  N=80, Completed, 
    No longer recruiting --> Completed Active, not recruiting --> Completed | N=60 --> 80
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  A Comparative Study Minisling Versus Transobturator (TOT)Sling (clinicaltrials.gov) -  Jun 21, 2017   
    P4,  N=145, Completed, 
    Active, not recruiting --> Completed | N=60 --> 80 Enrolling by invitation --> Completed | N=50 --> 145 | Trial primary completion date: Jan 2011 --> Dec 2011
  • ||||||||||  Trial primary completion date:  Gladiolus: Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms (clinicaltrials.gov) -  Jun 7, 2017   
    P=N/A,  N=465, Active, not recruiting, 
    Enrolling by invitation --> Completed | N=50 --> 145 | Trial primary completion date: Jan 2011 --> Dec 2011 Trial primary completion date: Jun 2017 --> Dec 2016
  • ||||||||||  Trial completion, Trial primary completion date, Surgery:  RUPO: Auriculotherapy for Prevention of Postoperative Urinary Retention (clinicaltrials.gov) -  May 19, 2017   
    P=N/A,  N=64, Completed, 
    Trial primary completion date: Jun 2017 --> Dec 2016 Recruiting --> Completed | Trial primary completion date: Apr 2017 --> May 2016
  • ||||||||||  Enrollment closed, Trial primary completion date:  Muscle Progenitor Cell Therapy for Urinary Incontinence (clinicaltrials.gov) -  Apr 19, 2017   
    P1/2,  N=10, Active, not recruiting, 
    N=135 --> 79 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Dec 2017
  • ||||||||||  Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
    Trial primary completion date:  Thrombolysis in Ischemic Spinal Cord Stroke (clinicaltrials.gov) -  Apr 13, 2017   
    P2,  N=12, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Oct 2017 --> Oct 2018
  • ||||||||||  Trial primary completion date:  Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) -  Mar 14, 2017   
    P=N/A,  N=40, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Feb 2017 --> Jun 2017
  • ||||||||||  Phase classification, Trial primary completion date:  Vitamin D Supplementation in Older Adults With Urinary Incontinence (clinicaltrials.gov) -  Mar 13, 2017   
    P=N/A,  N=69, Recruiting, 
    Trial primary completion date: Feb 2017 --> Jun 2017 Phase classification: P2/3 --> P=N/A | Trial primary completion date: Jan 2017 --> Jan 2018
  • ||||||||||  Trial completion:  Precise Transvaginal Tape Placement Trial (clinicaltrials.gov) -  Mar 1, 2017   
    P=N/A,  N=56, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial termination, HEOR:  InterStim Prospective Database (clinicaltrials.gov) -  Feb 15, 2017   
    P=N/A,  N=736, Terminated, 
    Active, not recruiting --> Completed N=3000 --> 736 | Enrolling by invitation --> Terminated; Shift in department's research interest
  • ||||||||||  Trial primary completion date:  Foot Neuromodulation for Nocturnal Enuresis (clinicaltrials.gov) -  Feb 15, 2017   
    P=N/A,  N=20, Enrolling by invitation, 
    N=3000 --> 736 | Enrolling by invitation --> Terminated; Shift in department's research interest Trial primary completion date: Sep 2016 --> Sep 2018
  • ||||||||||  Phase classification, Enrollment change, Trial withdrawal:  HIM-UP: Health Interventions in Men Undergoing Radical Prostatectomy (clinicaltrials.gov) -  Jan 26, 2017   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: Dec 2016 --> Mar 2017 Phase classification: P3 --> P=N/A | N=125 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Enrollment closed:  LILA: Lessening Incontinence Through Low-impact Activity (clinicaltrials.gov) -  Jan 26, 2017   
    P=N/A,  N=80, Active, not recruiting, 
    Phase classification: P3 --> P=N/A | N=125 --> 0 | Recruiting --> Withdrawn Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion:  InSite - OAB: InSite for Over Active Bladder (clinicaltrials.gov) -  Dec 1, 2016   
    P4,  N=571, Completed, 
    Recruiting --> Completed | N=40 --> 3 | Trial primary completion date: Aug 2016 --> Nov 2015 Active, not recruiting --> Completed
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Trial completion, Trial primary completion date:  Rituximab to Prevent Recurrence of Proteinuria (clinicaltrials.gov) -  Oct 21, 2016   
    P3,  N=43, Completed, 
    Completed --> Terminated Suspended --> Completed | Trial primary completion date: Feb 2017 --> Oct 2016
  • ||||||||||  Enrollment change, Trial primary completion date:  LILA: Lessening Incontinence Through Low-impact Activity (clinicaltrials.gov) -  Oct 4, 2016   
    P=N/A,  N=80, Recruiting, 
    N=50 --> 0 | Not yet recruiting --> Withdrawn N=50 --> 80 | Trial primary completion date: Sep 2016 --> Dec 2017
  • ||||||||||  Potiga (retigabine) / Bausch Health, GSK
    Trial termination, Trial primary completion date:  Risk of Urinary Retention With Retigabine (clinicaltrials.gov) -  Sep 29, 2016   
    P=N/A,  N=1, Terminated, 
    Withdrawn --> Completed Active, not recruiting --> Terminated | Trial primary completion date: Nov 2015 --> Sep 2016; This study was halted as the preliminary analysis revealed that the numbers were too low to warrant continuing the project
  • ||||||||||  Trial primary completion date:  CARESS: Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy (clinicaltrials.gov) -  Sep 29, 2016   
    P=N/A,  N=100, Recruiting, 
    Active, not recruiting --> Terminated | Trial primary completion date: Nov 2015 --> Sep 2016; This study was halted as the preliminary analysis revealed that the numbers were too low to warrant continuing the project Trial primary completion date: Jun 2016 --> Jun 2018
  • ||||||||||  Trial completion, Enrollment change:  Correlation of Albuminuria With Arterial Stiffness (clinicaltrials.gov) -  Aug 30, 2016   
    P=N/A,  N=152, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=456 --> 152
  • ||||||||||  Enrollment open, Enrollment change, Trial primary completion date:  Vitamin D Supplementation in Older Adults With Urinary Incontinence (clinicaltrials.gov) -  Aug 29, 2016   
    P2/3,  N=69, Recruiting, 
    Recruiting --> Completed | N=456 --> 152 Completed --> Recruiting | N=49 --> 69 | Trial primary completion date: Jan 2016 --> Jan 2017
  • ||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Trial completion, Trial primary completion date:  Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) (clinicaltrials.gov) -  Aug 24, 2016   
    P3,  N=380, Completed, 
    Completed --> Recruiting | N=49 --> 69 | Trial primary completion date: Jan 2016 --> Jan 2017 Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jul 2016